RSRowan Sultan

Rowan Sultan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rowan Sultan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Jelle Tichelaar

    Department of Internal Medicine Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands

    2 shared publications
  • Michael O. Reumerman

    Department of Internal Medicine Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands

    2 shared publications
  • Michiel A. van Agtmael

    Department of Internal Medicine Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands

    2 shared publications
  • Milan C. Richir

    Department of Internal Medicine Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands

    2 shared publications
  • Els Grijmans

    Hogeschool Inholland Amsterdam The Netherlands

    1 shared publication
  • Hans Springer

    Hogeschool Inholland Amsterdam The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Cross-cultural and international barriers and enablers to medication safety and pharmacotherapy: insights from a World Café study on interprofessional education

    by Rowan Sultan, Jan-Jaap Reinders, Michael O. Reumerman, Michiel A. van Agtmael, Milan C. Richir, Jelle Tichelaar

    Introduction: The prevalence of chronic illnesses and polypharmacy has made medication safety complex. While interprofessional collaboration has been proposed as a strategy to improve medication safety and pharmacotherapy, little is known about the barriers and enablers that influence its implementation in this context. This study aims to identify these barriers and enablers, using the Interprofessional Education for Collaborative Patient-Centred Practice (IECPCP) framework. Methods: A World Café study was carried out at the All Together Better Health XI conference in Doha, Qatar, in November 2023. Participants engaged in discussions on four key themes related to interprofessional education in pharmacotherapy and medication safety. Data were analyzed using the IECPCP framework. Results: Seventeen participants from seven countries identified 41 barriers and 75 enablers. Thematic analysis revealed six overarching domains: Culture and Attitude, Policy and Governance, Structure and Curriculum, Roles and Identity, Resources and Support, and Evaluation and Evidence. Key barriers included hierarchical norms and a lack of clarity about interprofessional roles at macro and meso levels, and interpersonal conflict and limited accountability at a micro level. Enablers included the promotion of open communication, leadership support, integration of interprofessional education into curricula, and the use of real-world examples to improve the relevance of training. Conclusion: National laws, healthcare policies, and cultural hierarchies hinder interprofessional education in pharmacotherapy and medication safety, and strict legal rules and professional responsibilities concerning prescribing complicate collaboration. Stimulating open communication between different professionals may help improve interprofessional collaboration and create more supportive conditions for safe prescribing and medication safety.

  • Open Access

    An Interprofessional Student‐Run Medication Review Program: The Clinical STOPP/START‐Based Outcomes of a Controlled Clinical Trial in a Geriatric Outpatient Clinic

    by Rowan Sultan, Tessa O. van Den Beukel, Michael O. Reumerman, Hester E. M. Daelmans, Hans Springer, Els Grijmans, Majon Muller, Milan C. Richir, Michiel A. van Agtmael, Jelle Tichelaar

    As the population ages, more people will have comorbid disorders and polypharmacy. Medication should be reviewed regularly in order to avoid adverse drug reactions and medication‐related hospital visits, but this is often not done. As part of our student‐run clinic project, we investigated whether an interprofessional student‐run medication review program (ISP) added to standard care at a geriatric outpatient clinic leads to better prescribing. In this controlled clinical trial, patients visiting a memory outpatient clinic were allocated to standard care (control group) or standard care plus the ISP team (intervention group). The medications of all patients were reviewed by a review panel (“gold standard”), resident, and in the intervention arm also by an ISP team consisting of a group of students from the medicine and pharmacy faculties and students from the higher education school of nursing for advanced nursing practice. For both groups, the number of STOPP/START‐based medication changes mentioned in general practitioner (GP) correspondence and the implementation of these changes about 6 weeks after the outpatient visit were investigated. The data of 216 patients were analyzed (control group = 100, intervention group = 116). More recommendations for STOPP/START‐based medication changes were made in the GP correspondence in the intervention group than in the control group (43% vs. 24%, P = < 0.001). After 6 weeks, a significantly higher proportion of these changes were implemented in the intervention group (19% vs. 9%, P = 0.001). The ISP team, in addition to standard care, is an effective intervention for optimizing pharmacotherapy and medication safety in a geriatric outpatient clinic.